Business Description
Oscar Health Inc
NAICS : 525120
SIC : 6321
ISIN : US6877931096
Share Class Description:
OSCR: Class ATotal Employee Number:
2,305Compare
Compare
Traded in other countries / regions
OSCR.USAOSCR.Mexico9VY.Germany1OSCR.Italy Index Membership
Russell 2000Russell 3000 IPO Date
2021-03-03Description
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.44 | |||||
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 0.68 | |||||
Interest Coverage | 38.21 | |||||
Piotroski F-Score | 8/9 | |||||
Beneish M-Score | -3.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.9 | |||||
3-Year EBITDA Growth Rate | 17.9 | |||||
3-Year EPS without NRI Growth Rate | 16 | |||||
3-Year FCF Growth Rate | 34.6 | |||||
3-Year Book Growth Rate | -7.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.75 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.43 | |||||
9-Day RSI | 47.89 | |||||
14-Day RSI | 50.19 | |||||
3-1 Month Momentum % | 40.62 | |||||
6-1 Month Momentum % | 130.21 | |||||
12-1 Month Momentum % | 82.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.2 | |||||
Shareholder Yield % | -2.07 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Net Margin % | 3.6 | |||||
EBITDA Margin % | 4.14 | |||||
FCF Margin % | 28.59 | |||||
OCF Margin % | 28.84 | |||||
ROE % | 40.05 | |||||
ROA % | 7.07 | |||||
3-Year ROIIC % | -82.89 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.76 | |||||
Forward PE Ratio | 18.89 | |||||
PE Ratio without NRI | 9.08 | |||||
Price-to-Owner-Earnings | 2.37 | |||||
PS Ratio | 0.61 | |||||
PB Ratio | 4.58 | |||||
Price-to-Tangible-Book | 4.58 | |||||
Price-to-Free-Cash-Flow | 2.39 | |||||
Price-to-Operating-Cash-Flow | 2.37 | |||||
EV-to-EBIT | 9.52 | |||||
EV-to-Forward-EBIT | 12.45 | |||||
EV-to-EBITDA | 9.09 | |||||
EV-to-Forward-EBITDA | 10.36 | |||||
EV-to-Revenue | 0.38 | |||||
EV-to-Forward-Revenue | 0.15 | |||||
EV-to-FCF | 1.32 | |||||
Price-to-GF-Value | 1.27 | |||||
Price-to-Projected-FCF | 0.58 | |||||
Price-to-Graham-Number | 1.36 | |||||
Earnings Yield (Greenblatt) % | 10.5 | |||||
FCF Yield % | 46.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:OSCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oscar Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15,318.633 | ||
| EPS (TTM) ($) | 1.4 | ||
| Beta | 4.1644 | ||
| 3-Year Sharpe Ratio | 0.89 | ||
| 3-Year Sortino Ratio | 1.94 | ||
| Volatility % | 76.27 | ||
| 14-Day RSI | 50.19 | ||
| 14-Day ATR ($) | 1.857612 | ||
| 20-Day SMA ($) | 30.385 | ||
| 12-1 Month Momentum % | 82.13 | ||
| 52-Week Range ($) | 10.69 - 33.548 | ||
| Shares Outstanding (Mil) | 308.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oscar Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oscar Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-12 | In 167 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-10 08:00 | In 166 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-10 | In 165 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 70 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 69 days | ||
| Analyst meeting for 2026 | 2026-09-16 09:00 | In 19 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 08:00 | 30.11 (-1.44%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 30.11 (-1.44%) | ||
| General meeting for 2026 | 2026-06-04 10:00 | 20.50 (-2.29%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 08:00 | 17.94 (-3.55%) |
Show
Entries
Oscar Health Inc Frequently Asked Questions
What is Oscar Health Inc(OSCR)'s stock price today?
The current price of OSCR is $30.47. The 52 week high of OSCR is $33.55 and 52 week low is $10.69.
When is next earnings date of Oscar Health Inc(OSCR)?
The next earnings date of Oscar Health Inc(OSCR) is 2026-11-06 Est..
Does Oscar Health Inc(OSCR) pay dividends? If so, how much?
Oscar Health Inc(OSCR) does not pay dividend.
Guru Commentaries on NYSE:OSCR
Longleaf Partners Small Cap Fund
Bearish
2025 Q3
What the manager wrote
Oscar Health reversed course from being a contributor last quarter to a detractor this quarter. Claims losses were much worse than expected in the first half of the year, and Oscar was unable to lose much less than others because of the way this unique market works, which hurt our appraisal. As the stock recovered later in the quarter, we sold the rest of our position as our price to value gap had closed. This ended up being a successful overall investment, and we are grateful to our partners at the company for leading it through volatile industry times.
Longleaf Partners Small-Cap Fund
Bullish
2025 Q2
What the manager wrote
Oscar Health – Health insurance and software company Oscar was a top contributor for the quarter. The company delivered a solid quarter operationally, effectively managing what was within its control despite market sentiment experiencing wild swings, largely driven by the latest draft of the Trump bill. We remain confident in the long-term potential for this company considering its differentiated offering for its members, and our aligned management partners who are on offense with a great balance sheet.
Press Release
Articles on Oscar Health Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers